D-133-2013 Class II Terminated
FDA drug recall D-133-2013 was initiated by West-Ward Pharmaceutical Corp. on Dec 5, 2012 and is designated Class II. Reason for recall: Presence of Foreign Substance: A complaint was received for black specks identified as stainless steel inclusions and cellulose with trace amounts of aluminum and iron-rich inclusions. The recall status is terminated (terminated May 16, 2014). Affected quantity: 60,289 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 30, 2013
- Initiation Date
- Dec 5, 2012
- Termination Date
- May 16, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 60,289 bottles
Product description
PredniSONE Tablets, USP, 20 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1477-01), b) 500-count tablets per bottle (NDC 0143-1477-05), and c) 1000-count tablets per bottle (NDC 0143-1477-10), Rx only, Manufactured by: West-ward Pharmaceutical Corp., Eatowntown, NJ 07724.
Reason for recall
Presence of Foreign Substance: A complaint was received for black specks identified as stainless steel inclusions and cellulose with trace amounts of aluminum and iron-rich inclusions.
Distribution pattern
Nationwide and Puerto Rico
Code information
Lot #: 68581A, 68581B, 68382A, 68382B, 68578A, 68578B, 68579A, 68580A, 68582A, 68582B, Exp 01/15
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-133-2013
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026